Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/2/2022
Zelixir Biotech Looks to Help Global Monkeypox Drug Development
6/1/2022
Xuanzhu and CTTQ-Akeso Tie Up to Develop Penpulimab for Solid Tumors
6/1/2022
Pharma Cos Accelerate Repositioning amid Rising Uncertainties and Macr...
5/31/2022
Rough Discussion On Experimental Data Submitted After Application Fili...
5/31/2022
CDE Issues the Technical Guidelines for Non-clinical Research and Asse...
5/31/2022
CDE Issues the Technical Guidelines for Pharmaceutical Studies and Eva...
5/31/2022
CDE Issues the Technical Guidelines for Pharmaceutical Studies and Eva...
5/31/2022
China to Expand Free HPV Vaccinations to Cover More People
5/31/2022
Recent Executive Moves
5/31/2022
Drug R&D and Product Registration News Digest May 2022 (4)
5/31/2022
Financial-related Company News Digest - May 2022
5/30/2022
CDE Issues the Technical Guidelines for Clinical Trials of Locally Adm...
5/30/2022
SMEI: Review of Chinese Retail Pharmacy Market (Offline and Online)
5/27/2022
GSK's 2-Dose HPV Vaccine Cervarix Wins Approval in China To Prevent Ce...
5/27/2022
NMPA Issues Chinese GMP's Clinical Trial Drug Appendix
5/27/2022
Shanghai Initiates Second Round of Budget Medical Insurance Scheme Huh...
5/27/2022
Tracking the Rise of CAR-Ts in China: The Dawn of An Immunotherapy Sup...
5/26/2022
China's First Decision In A Case Initiated Under Its Patent Linkage Sy...
5/26/2022
USTR Releases Special 301 Report On IP Protection With Special Section...
5/26/2022
April Licensing Trends Show Chinese Biotechs Expanding Beyond Oncology...
5/26/2022
Ten Trends of China's Pharmaceutical Industry in 2021 (PharmCube)
5/26/2022
Henlius and Abbott Enter Semi-Exclusive License Deal for Rituximab and...
5/26/2022
Data Snapshot: Top 20 Domestic Class 1 New Drugs by Sales in 2021
5/26/2022
Pharma Trading Platform Yaoshibang Applies for Hong Kong IPO
5/25/2022
CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
5/25/2022
Hanmi Launches High-blood Pressure Drug Meiyaping (Amosartan) in China
5/25/2022
Beijing Health Chief Fired Following Investigation
5/25/2022
State Council Issues Notice on Major Tasks for Deepening Healthcare Re...
5/25/2022
Real-World Evidence Is Becoming a Pivotal Component in Chinese Healthc...
5/24/2022
New Draft Implementing Regulations Propose Key Changes for Pharmaceuti...
Page:
139
/
775
Total number of articles:
23243
:
[First]
[<<]
[137]
[138]
[139]
[140]
[141]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit